Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Endocrinology | Family Medicine | Geriatrics | Gynecology | Internal Medicine | Neurology | Nursing | Pathology | Psychiatry | Journal

Back to Journal Articles

High Estradiol Levels Linked to Dementia in Women

Last Updated: January 29, 2014.

 

Risk even higher in women who also have diabetes

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Postmenopausal women with high estradiol levels have a two-fold higher risk of developing dementia, but the risk is 14-fold higher if they also have diabetes, according to a study published online Jan. 29 in Neurology.

WEDNESDAY, Jan. 29, 2014 (HealthDay News) -- Postmenopausal women with high estradiol levels have a two-fold higher risk of developing dementia, but the risk is 14-fold higher if they also have diabetes, according to a study published online Jan. 29 in Neurology.

Laure Carcaillon, Ph.D., from the Institut National de la Santé et de la Recherche Médicale in Villejuif, France, and colleagues examined the association between blood estradiol levels and the development of dementia in postmenopausal women aged 65 years or older. Five hundred forty-three women did not develop dementia and 132 women developed dementia after four years of follow up.

The researchers found that the risk of dementia was significantly higher for both the lowest quartile (hazard ratio [HR], 2.4) and highest quartile (HR, 2.2) of estradiol levels after adjusting for other variables. Women with higher total estradiol levels had a significantly higher risk of dementia if they also had diabetes (HR, 14.2), compared with no diabetes (HR, 3.4). Similar results were found for bioavailable estradiol, while no association was observed for total testosterone. Adjusting for inflammatory and blood coagulation markers had no effect.

"High estradiol level is an independent predictor of incident dementia, particularly in postmenopausal women with diabetes," Carcaillon and colleagues conclude.

Two authors disclosed financial ties to pharmaceutical companies.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.


Previous: Botanical Extracts May Aid in Lightening Hyperpigmentation Next: Marital History and Support Linked to Bone Health

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.